Vaxcyte names new chief medical and legal officers, moves up OPUS-1 data timingSep 3Clinical readoutVaxcyte, Inc.
Traws Pharma files prospectus supplement for up to $5.58 million at-the-market stock saleJul 10FinancingTraws Pharma, Inc.
Sign inSign in